Market Place
Sourcing Support
NRx Pharmaceuticals Presents Landmark NRX-101 Trial For Suicidal Bipolar
28 May 2024 //
PR NEWSWIRE
NRx keeps antidepressant`s blockbuster hopes alive despite flop
30 Apr 2024 //
FIERCE BIOTECH
Drugs for TB, hypertension and antacids amongst those failing quality tests
26 Dec 2019 //
LIVE MINT
NeuroRx Receives FDA Breakthrough Therapy Designation for NRX-101
13 Nov 2018 //
BUSINESSWIRE
Zhejiang Hisun Pharmaceutical, Co., Ltd. (Yantou Campus) Fails EDQM Inspection
19 Sep 2016 //
EDQM
Strides Shasun Receives Positive WHO Inspection Report for Formulation Facility
05 Feb 2016 //
TWOFOUR INSIGHT
Hope And Hype For New Type Of Antidepressant
26 Jun 2015 //
FORBES
Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.
02 May 2015 //
FIERCE PHARMA MFG
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.